VTGN · Vistagen Therapeutics, Inc.
$0.24
+0.01 (+4.64%)
At close · Jul 29
Going-concern doubt
— flagged Jun 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 15, 2026, the issuance date of the consolidated financial statements as of and for the year ended March 31, 2026, there is uncertainty about whether the Company’s combined cash, cash equivalents, and marketable securities will be sufficient to fund operations beyond twelve months from the issuance date of these consolidated financial statements and therefore the Company concluded that substantial doubt existed about the Company’s ability to continue as a going concern.”View the 10-K filed Jun 15, 2026
Market Cap
$9.55M
Shares
41.03M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-30 | Vistagen Reports Corporate Update | Event |
| 2026-05-20 | 2026 RBC Capital Markets Global Healthcare Conference | Conference |
| 2026-03-17 | Stifel 2026 Virtual CNS Forum | Event |
Source: https://ir.vistagen.com/